Nash

Gold Stocks Surge Back (NYSEARCA:GDX)

guvendemir/E+ via Getty Images The gold miners’ stocks surged back this week, blasting higher out of early-year weakness. Those big-and-fast gains were fueled by gold’s own, which shot up without any news catalyst. Seeing battered gold stocks showing signs of life has piqued traders’ interest, starting to shift sector sentiment back towards bullish. These leveraged …

Gold Stocks Surge Back (NYSEARCA:GDX) Read More »

Retailer Kohl’s said to have received takeover offer from consortium backed by activist hedge fund

A consortium backed by activist hedge fund Starboard Value LP has offered roughly $9 billion to buy department store Kohl’s Corp.  KSS, -2.60%, according to people familiar with the matter. A group led by Acacia Research Corp. ACTG, -0.69%, which Starboard controls, offered to buy the department-store chain for $64 a share in cash Friday, the people …

Retailer Kohl’s said to have received takeover offer from consortium backed by activist hedge fund Read More »

Markets are expected to remain on edge as the Fed meets in the week ahead

Traders on the floor at the NYSE, Jan. 13, 2022. Source: NYSE Market turbulence is likely to continue in the week ahead as the Federal Reserve meets and the biggest of big tech —Apple and Microsoft — report earnings. Stocks on Friday closed out their worst week since 2020, with big losses in technology and …

Markets are expected to remain on edge as the Fed meets in the week ahead Read More »

Xbox Head Hopes to Revive Dormant Activision Franchises

Top Games Guitar Hero is among the franchises Activision has left untapped in recent years. / Theo Wargo/GettyImages Microsoft’s CEO of Gaming Phil Spencer says he’s looking to revive Activision franchises that have been left to languish once Activision Blizzard has been brought into the fold at Microsoft. “I was looking at the IP list, …

Xbox Head Hopes to Revive Dormant Activision Franchises Read More »

Discover Financial Services 2022 Q4 – Results – Earnings Call Presentation (NYSE:DFS)

This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with …

Discover Financial Services 2022 Q4 – Results – Earnings Call Presentation (NYSE:DFS) Read More »

China transport ministry summons freight-delivery platforms, warns Didi, other ride-hailing firms

China’s Ministry of Transport has summoned four leading freight-delivery platform operators and warned four internet ride-hailing companies over recent driver complaints, in a sign of Beijing’s continued scrutiny of the country’s massive tech sector after a year-long crackdown. The ministry on Friday said it has summoned four internet freight delivery firms, including the cargo businesses …

China transport ministry summons freight-delivery platforms, warns Didi, other ride-hailing firms Read More »

Stocks making the biggest moves after hours: Netflix, CSX & more

In this photo illustration the Netflix logo in the App Store seen displayed on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Check out the companies making headlines in after-hours trading: Netflix — Netflix shares dropped 19% in extended trading after the company’s quarterly report showed slowing subscriber growth. The …

Stocks making the biggest moves after hours: Netflix, CSX & more Read More »

Esperion Therapeutics (ESPR): A Potential ‘Bio Boom’ Or Bust In 2022

Vertigo3d/E+ via Getty Images Esperion Therapeutics (ESPR) has made significant developments over the past months to help ensure the company’s long-term goal to become a recognized leader in the treatment of cardiovascular disease. Firstly, Esperion is instituting a transformative long-term growth plan to enhance the company’s efficiency while delivering reliable growth. These changes should limit …

Esperion Therapeutics (ESPR): A Potential ‘Bio Boom’ Or Bust In 2022 Read More »

Scroll to Top